HIGHLIGHTS
- who: Mohammad Bagher Oghazian from the Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran have published the paper: Aspirin versus placebo on estrogen levels in postmenopausal women: a double-blind randomized controlled clinical trial, in the Journal: (JOURNAL)
- what: This study aimed to evaluate the effect of in postmenopausal women. The authors intended the administration of low-dose aspirin 100 mg/day vs. placebo for 6 weeks to assess the effect of a short time of aspirin use on estradiol (circulating estrogen) and sex hormone-binding globulin to measure . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.